India, May 6 -- Insulet Corporation (PODD), a medical device company, on Wednesday reported significantly higher first-quarter profit, driven by strong revenue growth, and raised its full-year sales outlook. Shares were up more than 3% in pre-market trading.
Net income more than doubled to $91.1 million, or $1.30 per share, from $35.4 million, or $0.50 per share, in the prior year
Excluding one-time items, adjusted earnings were $99.8 million, or $1.42 per share.
Operating income rose to $122.1 million from $88.8 million last year.
Adjusted operating income was $133.5 million.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Revenue jumped 33.9% to $761.7 million, or 30.1% in constant currency, exce...